Blog

Mar 10, 2025, 07:31

ASCO Advocacy, AANS/CNS and 40+ Specialty Groups Raise Concerns Over New NIH Overhead Cost Policy

American Society of Clinical Oncology (ASCO) shared a post on X by AANS/CNS Washington Committee for Neurological Surgery, adding:

“ASCO Advocacy joined the American Association of Neurological Surgeons/Congress of Neurological Surgeons (AANS/CNS DC Office) and 40+ specialty groups in expressing concerns over new NIH policy limiting how much research institutions can be reimbursed for overhead costs.”

Quoting AANS/CNS Washington Committee for Neurological Surgery’s post:

” ‘NIH-funded research has been the cornerstone of U.S. leadership in biomedical science, driving bold discoveries that improve patient care,’ states Alexander Khalessi, NIH’s new policy on indirect cost rates for grants jeopardizes medical innovation.

AANS, CNS and over 40 organisations are urging a collaborative solution.

Jay Bhattacharya, Office of Management and Budget, let’s work together.”

ASCO Advocacy, AANS/CNS and 40+ Specialty Groups Raise Concerns Over New NIH Overhead Cost Policy

Read further.

More posts featuring ASCO.

AANS/CNS DC Office AANS/CNS Washington Committee for Neurological Surgery Alexander Khalessi American Association of Neurological Surgeons American Society of Clinical Oncology ASCO cancer Congress of Neurological Surgeons neurosurgery NIH OncoDaily Oncology

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer

Daiichi Sankyo's and Astrazeneca's press release on ENHERTU®: Latest Updates from DESTINY-Gastric04 trial

13-year-old Cancer Survivor Sworn in as a Secret Service agent by President Trump - The White House

The European Parliament Intergroup on Cancer and Rare Diseases has been set in motion - ECO